AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36026800 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 62
Study 34290862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual CoQ10 (400 mg/d)
Number of subjects: 40
Study 33742481 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol infusion
Number of subjects: 37
Study 33742481 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 37
Study 32170665 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA with antithrombotic therapy
Number of subjects: 1877
Study 32170665 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA without antithrombotic therapy
Number of subjects: 1877
Study 32170665 — intervention group
Group type: COMPARATOR
Intervention: Placebo with antithrombotic therapy
Number of subjects: 1877
Study 32170665 — intervention group
Group type: COMPARATOR
Intervention: Placebo without antithrombotic therapy
Number of subjects: 1877
Study 32170665 — intervention group
Group type: COMPARATOR
Intervention: Any antithrombotic therapy
Number of subjects: 1877
Study 32170665 — intervention group
Group type: COMPARATOR
Intervention: No antithrombotic therapy
Number of subjects: 1877
Study 33431073 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosis risk calculator using neurocognitive, clinical, medical, and environmental variables
Number of subjects: 632
Study 33431073 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Global Assessment Scale, delusions of predicting the future, percent married in neighborhood
Number of subjects: 632
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty phenotype (FP) assessment
Number of subjects: 136
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 70 or older
Number of subjects: 136
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 136
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle mass
Number of subjects: 136
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: HF functional classes I
Number of subjects: 136
Study 34112582 — intervention group
Group type: EXPERIMENTAL
Intervention: HF functional classes II
Number of subjects: 136
Study 32112104 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide exposure (DDT, pyrethroids, carbamates, organophosphates)
Number of subjects: 0
Study 32112104 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance genes (kdr L1014F, L1014S, N1575Y; ace1 G119S)
Number of subjects: 0
Study 32112104 — intervention group
Group type: COMPARATOR
Intervention: Environmental and socio-economic factors
Number of subjects: 0
Study 33741235 — intervention group
Group type: EXPERIMENTAL
Intervention: PhoRTE
Number of subjects: 24
Study 33741235 — intervention group
Group type: EXPERIMENTAL
Intervention: PhoRTE + EMST
Number of subjects: 24
Study 34915186 — intervention group
Group type: EXPERIMENTAL
Intervention: e-learning group (n=59)
Number of subjects: 167
Study 34915186 — intervention group
Group type: EXPERIMENTAL
Intervention: EDD group (n=53)
Number of subjects: 167
Study 34915186 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=55)
Number of subjects: 167
Study 35782635 — intervention group
Group type: EXPERIMENTAL
Intervention: Training about PBIS
Number of subjects: 40
Study 35782635 — intervention group
Group type: EXPERIMENTAL
Intervention: Training plus RS3 (Rural School Support Strategies)
Number of subjects: 40
Study 35782635 — intervention group
Group type: COMPARATOR
Intervention: Control group (enhanced condition)
Number of subjects: 40
Study 32503946 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 10 mg/kg
Number of subjects: 0
Study 32503946 — intervention group
Group type: COMPARATOR
Intervention: ipilimumab 3 mg/kg
Number of subjects: 0
Study 32503946 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 10 mg/kg (subgroup with asymptomatic brain metastasis)
Number of subjects: 0
Study 32503946 — intervention group
Group type: COMPARATOR
Intervention: ipilimumab 3 mg/kg (subgroup with asymptomatic brain metastasis)
Number of subjects: 0
Study 32503946 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 10 mg/kg (wild-type BRAF tumors)
Number of subjects: 0
Study 32503946 — intervention group
Group type: COMPARATOR
Intervention: ipilimumab 3 mg/kg (wild-type BRAF tumors)
Number of subjects: 0
Study 32503946 — intervention group
Group type: EXPERIMENTAL
Intervention: ipilimumab 10 mg/kg (mutant BRAF tumors)
Number of subjects: 0
Study 32503946 — intervention group
Group type: COMPARATOR
Intervention: ipilimumab 3 mg/kg (mutant BRAF tumors)
Number of subjects: 0
Study 33467877 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of DWI lesions
Number of subjects: 466
Study 33629548 — intervention group
Group type: EXPERIMENTAL
Intervention: T16Ainh‐A01
Number of subjects: 0
Study 33629548 — intervention group
Group type: COMPARATOR
Intervention: DMSO
Number of subjects: 0
Study 33629548 — intervention group
Group type: COMPARATOR
Intervention: Senescent group (P12)
Number of subjects: 0
Study 36432453 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinue central access at an enteral feeding volume of 100 mL/kg/day
Number of subjects: 211
Study 36432453 — intervention group
Group type: COMPARATOR
Intervention: Standard discontinuation at an enteral feeding volume of 140 mL/kg/day
Number of subjects: 211
Study 32385918 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine
Number of subjects: 84
Study 32385918 — intervention group
Group type: COMPARATOR
Intervention: Biweekly Gemcitabine and Carboplatin
Number of subjects: 84
Study 35670748 — intervention group
Group type: EXPERIMENTAL
Intervention: Press tack acupuncture
Number of subjects: 72
Study 35670748 — intervention group
Group type: COMPARATOR
Intervention: Press tack placebo
Number of subjects: 72
Study 35801367 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based flipped classroom (SBFC)
Number of subjects: 326
Study 35801367 — intervention group
Group type: COMPARATOR
Intervention: Traditional simulation (TS)
Number of subjects: 326
Study 33955599 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide plus androgen deprivation therapy
Number of subjects: 92
Study 33955599 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus androgen deprivation therapy
Number of subjects: 92
Study 32980559 — intervention group
Group type: EXPERIMENTAL
Intervention: Auriculotherapy (ear seeds placed on shoulder and muscle relaxation points from 2 hours prior to surgery until 24 hours after surgery)
Number of subjects: 90
Study 32980559 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ear seeds placed on placebo points)
Number of subjects: 90
Study 36052728 — intervention group
Group type: EXPERIMENTAL
Intervention: VOCs based COVID-19 detection model
Number of subjects: 201
Study 34028986 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-MIBG therapy at a dose of 15 mCi/kg
Number of subjects: 68
Study 34028986 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-MIBG + Bu/Mel therapy
Number of subjects: 68
Study 34028986 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-MIBG therapy at doses of 12, 15, and 18 mCi/kg
Number of subjects: 68
Study 34028986 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I-MIBG therapy
Number of subjects: 68
Study 32234531 — intervention group
Group type: EXPERIMENTAL
Intervention: Limiting portions of problem foods
Number of subjects: 186
Study 32234531 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-portioned foods
Number of subjects: 186
Study 32234531 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance strategies for problem foods
Number of subjects: 186
Study 35551084 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic medical record (EMR) based paediatric asthma pathway, online learning modules, in‐person training for allied health teams in asthma education, and a clinical dashboard for patient management.
Number of subjects: 37
Study 34400339 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 160 ppm for 30 min twice daily
Number of subjects: 29
Study 35144945 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrate (PCC) 4-factor (15 IU/kg)
Number of subjects: 594
Study 35144945 — intervention group
Group type: COMPARATOR
Intervention: Fresh frozen plasma (FFP) (10 mL/kg)
Number of subjects: 594
Study 33971951 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple cognitive task intervention (memory cue + mental rotation instructions + computer game 'Tetris' for at least 20 min)
Number of subjects: 16
Study 33971951 — intervention group
Group type: COMPARATOR
Intervention: Control (podcast, similar time)
Number of subjects: 16
Study 33150554 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarifying dialogue
Number of subjects: 80
Study 33150554 — intervention group
Group type: EXPERIMENTAL
Intervention: Key information mentioned first
Number of subjects: 80
Study 33150554 — intervention group
Group type: COMPARATOR
Intervention: Chronological order
Number of subjects: 80
Study 33150554 — intervention group
Group type: COMPARATOR
Intervention: Unidirectional information exchange
Number of subjects: 80
Study 32166877 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin alongside seasonal malaria chemoprevention (sulfadoxine-pyrimethamine plus amodiaquine)
Number of subjects: 19578
Study 32166877 — intervention group
Group type: COMPARATOR
Intervention: Placebo alongside seasonal malaria chemoprevention (sulfadoxine-pyrimethamine plus amodiaquine)
Number of subjects: 19578
Study 33920488 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practices (monitoring, pressure to eat, restriction)
Number of subjects: 316
Study 33920488 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental perception of children's weight
Number of subjects: 316
Study 33920488 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education for parents
Number of subjects: 316
Study 34363942 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuing antibiotic therapy
Number of subjects: 467
Study 34363942 — intervention group
Group type: COMPARATOR
Intervention: Usual strategy of continuing antibiotic treatment
Number of subjects: 467
Study 33618685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application (Dental Surgical Forceps application version 2.1.0.0)
Number of subjects: 67
Study 33618685 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile application)
Number of subjects: 67
Study 33618685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application
Number of subjects: 67
Study 33559021 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS)
Number of subjects: 39
Study 32390729 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-week soleus stretch (knee flexed) and gastrocnemius stretch (knee extended)
Number of subjects: 33
Study 32390729 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching intervention)
Number of subjects: 33
Study 32390729 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 33
Study 35615439 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD/CRT-D implantation with remote management
Number of subjects: 60
Study 35615439 — intervention group
Group type: COMPARATOR
Intervention: Routine intervention (Control group)
Number of subjects: 60
Study 34380747 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain (NfL) levels measured in ALS cases within 5 years of diagnosis
Number of subjects: 84
Study 34380747 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma neurofilament light chain (NfL) levels measured in ALS cases further away from diagnosis
Number of subjects: 84
Study 34380747 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of metabolites with pre‐diagnostic NfL levels in ALS cases
Number of subjects: 84
Study 36449307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 7.5 mg
Number of subjects: 264
Study 36449307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 15 mg
Number of subjects: 264
Study 36449307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziltivekimab 30 mg
Number of subjects: 264
Study 36449307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 33832658 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric balloons
Number of subjects: 0
Study 33832658 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle interventions
Number of subjects: 0
Study 32998769 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher PEEP (6-8 cmH2O)
Number of subjects: 216
Study 32998769 — intervention group
Group type: COMPARATOR
Intervention: Lower PEEP (3-5 cmH2O)
Number of subjects: 216
Study 33739852 — intervention group
Group type: COMPARATOR
Intervention: Low-risk patients (with favorable cytogenetics) compared to standard-risk patients (with identical therapy but without favorable or unfavorable cytogenetics)
Number of subjects: 1857
Study 33222923 — intervention group
Group type: EXPERIMENTAL
Intervention: Ekso‐GT (overground exoskeleton)
Number of subjects: 30
Study 33222923 — intervention group
Group type: COMPARATOR
Intervention: Standard gait training (control group)
Number of subjects: 30
Study 36334430 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemically protected sodium butyrate (CSB) 1,000 mg/kg
Number of subjects: 192
Study 36334430 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (enramycin 8 mg/kg and aureomycin 100 mg/kg)
Number of subjects: 192
Study 36334430 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 192
Study 34185116 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 671
Study 34185116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671
Study 34924009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive games platform by HappyNeuron (HN)
Number of subjects: 100
Study 34924009 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Non-Training group)
Number of subjects: 100
Study 36138191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric arterial embolization (BAE)
Number of subjects: 7
Study 33966029 — intervention group
Group type: EXPERIMENTAL
Intervention: qHPV (Gardasil-4, MSD)
Number of subjects: 126
Study 33966029 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 32699231 — intervention group
Group type: EXPERIMENTAL
Intervention: placebo + LSD (100 µg)
Number of subjects: 24
Study 32699231 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT2A receptor antagonist ketanserin (40 mg) + LSD (100 µg)
Number of subjects: 24
Study 32699231 — intervention group
Group type: COMPARATOR
Intervention: placebo + placebo
Number of subjects: 24
Study 36071112 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (8 mg)
Number of subjects: 79
Study 32673189 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative message featuring negative consequences of nicotine addiction
Number of subjects: 0
Study 33989797 — intervention group
Group type: COMPARATOR
Intervention: PRESSURE
Number of subjects: 35
Study 33989797 — intervention group
Group type: EXPERIMENTAL
Intervention: BALANCE
Number of subjects: 35
Study 32565848 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocurcumin (BCM-95)
Number of subjects: 121
Study 32565848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 37902943 — intervention group
Group type: EXPERIMENTAL
Intervention: IA 40 mg TCA followed by IA 0.07 mg LOR
Number of subjects: 40
Study 37902943 — intervention group
Group type: EXPERIMENTAL
Intervention: IA 0.07 mg LOR followed by IA 40 mg TCA
Number of subjects: 40
Study 37902943 — intervention group
Group type: COMPARATOR
Intervention: Both treatment sequences
Number of subjects: 40
Study 32070556 — intervention group
Group type: EXPERIMENTAL
Intervention: MIPO with percutaneous lag screw (Group-B)
Number of subjects: 42
Study 32070556 — intervention group
Group type: COMPARATOR
Intervention: MIPO without lag screw (Group-A)
Number of subjects: 42
Study 32070556 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group-A and Group-B)
Number of subjects: 42
Study 34037468 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized, goal-centered, and administrative electronic messages for 12 weeks
Number of subjects: 890
Study 34037468 — intervention group
Group type: COMPARATOR
Intervention: Administrative messages
Number of subjects: 890
Study 32895744 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised saccharin solution
Number of subjects: 35
Study 32895744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 34184798 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot buprenorphine (CAM2038 weekly for 4 weeks then monthly)
Number of subjects: 67
Study 34184798 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot buprenorphine (CAM2038)
Number of subjects: 67
Study 34184798 — intervention group
Group type: COMPARATOR
Intervention: Daily oral methadone
Number of subjects: 67
Study 34016738 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (5 mg/d)
Number of subjects: 57
Study 32991229 — intervention group
Group type: EXPERIMENTAL
Intervention: Myomectomy
Number of subjects: 0
Study 32991229 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 0
Study 32991229 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence of uterine leiomyoma
Number of subjects: 0
Study 32991229 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year incidence in the 26-30 age group
Number of subjects: 0
Study 32535338 — intervention group
Group type: EXPERIMENTAL
Intervention: Play Orbit (n = 50)
Number of subjects: 139
Study 32535338 — intervention group
Group type: EXPERIMENTAL
Intervention: Play Orbit and CSA lessons (n = 55)
Number of subjects: 139
Study 32535338 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 34)
Number of subjects: 139
Study 32535338 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete all of Orbit
Number of subjects: 139
Study 32535338 — intervention group
Group type: EXPERIMENTAL
Intervention: Did not complete the game
Number of subjects: 139
Study 36316874 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (operator stood in the patient's axillary line)
Number of subjects: 44
Study 34804266 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-informed (weighted modality)
Number of subjects: 272
Study 34804266 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment-informed (secure base priming)
Number of subjects: 272
Study 34804266 — intervention group
Group type: COMPARATOR
Intervention: Control (no designated coping strategy)
Number of subjects: 272
Study 35769196 — intervention group
Group type: EXPERIMENTAL
Intervention: Date seed powder (26 g/d)
Number of subjects: 36
Study 35769196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35230053 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Dose Pindolol
Number of subjects: 0
Study 35230053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32235690 — intervention group
Group type: EXPERIMENTAL
Intervention: Steamed potato bread (raw wheat flour to cooked potato flour ratio of 3:7)
Number of subjects: 4
Study 32235690 — intervention group
Group type: COMPARATOR
Intervention: Steamed wheat bread (100% raw wheat flour)
Number of subjects: 4
Study 36169433 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment (Group B)
Number of subjects: 134
Study 36169433 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group A)
Number of subjects: 134
Study 32530765 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost radiotherapy (36 Gy total dose) after single or tandem autologous stem-cell transplantation
Number of subjects: 323
Study 32530765 — intervention group
Group type: COMPARATOR
Intervention: Single SCT with 21.6 Gy radiotherapy (no boost)
Number of subjects: 323
Study 32530765 — intervention group
Group type: EXPERIMENTAL
Intervention: Single SCT with boost radiotherapy (36 Gy total dose) for incomplete resection
Number of subjects: 323
Study 32530765 — intervention group
Group type: COMPARATOR
Intervention: Single SCT with 21.6 Gy radiotherapy (no boost) for incomplete resection
Number of subjects: 323
Study 35504635 — intervention group
Group type: EXPERIMENTAL
Intervention: PMP-I (Problem Management Plus for Immigrants)
Number of subjects: 232
Study 35504635 — intervention group
Group type: COMPARATOR
Intervention: Community support services pamphlets (Control)
Number of subjects: 232
Study 35504635 — intervention group
Group type: EXPERIMENTAL
Intervention: PMP-I
Number of subjects: 232
Study 33529381 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless administration of enamel matrix derivative (EMD) as adjunct to re‐instrumentation
Number of subjects: 44
Study 33529381 — intervention group
Group type: COMPARATOR
Intervention: Re‐instrumentation without adjunctive EMD (control)
Number of subjects: 44
Study 34083204 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid anxiety disorder in patients with BD
Number of subjects: 372
Study 34083204 — intervention group
Group type: EXPERIMENTAL
Intervention: Comorbid anxiety disorder in first-degree relatives (UR)
Number of subjects: 372
Study 34083204 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based patient-reported anxiety symptoms
Number of subjects: 372
Study 34083204 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with comorbid anxiety disorder
Number of subjects: 372
Study 32150296 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum tolerated dose combinations from the first stage of the trial
Number of subjects: 0
Study 32150296 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive randomization of patients to dose combinations
Number of subjects: 0
Study 35906011 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved diet quality
Number of subjects: 0
Study 35906011 — intervention group
Group type: EXPERIMENTAL
Intervention: Investments in school food programs
Number of subjects: 0
Study 33594103 — intervention group
Group type: EXPERIMENTAL
Intervention: KNO3 (2.5% and 5%)
Number of subjects: 5
Study 33594103 — intervention group
Group type: EXPERIMENTAL
Intervention: SiO2 (3% and 3.5%)
Number of subjects: 5
Study 33594103 — intervention group
Group type: EXPERIMENTAL
Intervention: Salicylic acid (1 mM and 2.5 mM)
Number of subjects: 5
Study 33594103 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 5
Study 32423920 — intervention group
Group type: EXPERIMENTAL
Intervention: Deltamethrin-resistant mosquitoes
Number of subjects: 0